Develop and apply human in vitro models and functional assay workflows to support translational research programs.
Generate high-quality experimental data to characterize the mode of action of novel therapeutic candidates in cardiovascular and renal indications.
Independently perform human cell culture, transfection, gene editing, and assay workflows with strong attention to scientific rigor, reproducibility, and data quality.
Contribute to the design, optimization, and continuous improvement of experimental approaches and assay performance.
Analyze, interpret, and clearly present experimental results to project teams and stakeholders.
Maintain accurate documentation of experimental work and support implementation of laboratory best practices and quality standards.
Ensure compliance with laboratory safety procedures and contribute to a safe, well-organized, and collaborative working environment.
Work closely with scientists across projects and functions, contributing to a highly interactive and team-oriented research setting.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.